CLINICAL_TRIALS
trial_result
· 2025-03-17
Clinical Trial Update: Study to Investigate the Use of Acalabrutinib in the Treatment of Patients With Chronic Lymphocytic Leukemia [Phase 3]
Summary
A Phase 3 study evaluating acalabrutinib in patients with chronic lymphocytic leukemia has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: PETHEMA Foundation | Conditions: Chronic Lymphocytic Leukemia- Binet Staging System | Phase 3 | Status: COMPLETED